荣昌生物：第三季度净利润亏损1.01亿元

Core Viewpoint - Rongchang Biotech reported a third-quarter revenue of 622 million yuan, representing a year-on-year increase of 33.13%, while net profit showed a loss of 101 million yuan [1] - For the first three quarters, the company achieved a revenue of 1.72 billion yuan, marking a year-on-year growth of 42.27%, with a net profit loss of 551 million yuan [1] Financial Performance - Third-quarter revenue: 622 million yuan, up 33.13% year-on-year [1] - Third-quarter net profit: loss of 101 million yuan [1] - Year-to-date revenue (first three quarters): 1.72 billion yuan, up 42.27% year-on-year [1] - Year-to-date net profit: loss of 551 million yuan [1]